Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ilex Capital Partners is a London-based multi-strategy investment management firm founded in 2023 by former Citadel portfolio managers Adam Heitler and David S. Miller. The firm is notable for its significant scale, launching with approximately $1.85 billion in assets under management, one of the largest hedge fund debuts in Europe in recent years. Co-founder David Miller's background as the former head of healthcare investing at Citadel’s Global Equities unit provides the firm with deep expertise in the life sciences and healthcare sectors. While the firm operates as a hedge fund and does not develop proprietary therapeutic products, its significant focus on healthcare equities makes it a major institutional player in the biotechnology market. The firm maintains offices in London and New York, employing a sophisticated approach to capital allocation across global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ilex Capital Partners.